This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Adverse events were mostly mild and resolved spontaneously. A 2017 literature review by the National Academy of Sciences, Engineering, and Medicine concluded , “There is conclusive or substantial evidence that cannabis or cannabinoids are effective for the treatment of chronic pain in adults.”
Evidence-based Complementary and Alternative Medicine published an article titled “Post-Traumatic Stress Disorder: Evidence-Based Research for the Third Millennium” which describes how profound the symptoms of PTSD can be: “Traumatic events are profoundly stressful. Women tend to experience different traumas than men.
Cannabinoid receptors CB1 and CB2 are the definitive and best-known targets of endogenous and plant-derived cannabinoids, but they’re far from the only ones. Two recent papers reiterate the point that to really understand cannabinoids (especially CBD) and the ECS, it’s essential to get to know the PPARs. And it worked.
However, these treatments have not proven to be wholly effective in managing the symptoms of depression. For some individuals, conventional treatments only worsen the symptoms of depression. This has spurred significantly greater interest in alternative remedies, including using cannabis for mental health treatment.
Post-Traumatic Stress Disorder (PTSD) is a multifaceted mental health condition triggered by experiencing or witnessing traumatic events, persistently manifesting in symptoms like flashbacks, severe anxiety, and disrupted sleep. Research suggests that cannabinoids may modulate these processes, potentially offering relief from PTSD symptoms.
“Our goal with this study is to enhance the existing treatment’s efficacy through adding CBD to create a new standard of care, potentially improving and extending glioblastoma patients’ quality of life.” These statements relate to future events or future performance. Chief Medical Officer, Enveric Biosciences.
The National Academies of Sciences reports that PTSD is a stressor-related disorder which develops as a result of a patient’s exposure to a traumatic event. The endocannabinoid system consists of cannabinoid receptors all over the body. 5 cannabis strains to treat PTSD?
Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. You have said that cannabigerol, or CBG, is one of your favorite cannabinoids. Is that because CBG is a precursor for the other plant cannabinoids?
The Academic Cannabis Conference , produced by News Joint Events , is pleased to announce its full presenter lineup and schedule. at the Garden Grove Event Center in Carbondale on May 4. Sharma’s studies aims to offer strategic insights to inform cultivation practices and optimize cannabinoid production. 3:30 p.m. – 3:30 p.m. –
SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. The primary safety objective of the study will be to assess absolute and relative frequencies of Serious Adverse Events (SAEs) for the whole population and separately for SCI-110 and placebo groups.
Neil Mahapatra is a co-founder of the Oxford Cannabinoid Technologies (OCT) which floated on the LSE in the May this year, he is also founder of UK venture capital business Kingsley Capital Partners (KCP). Oxford Cannabinoid Technologies’ Shares Fall A Further 20% As Chairman Stands Down Following Market Rule Breach.
Traditional treatment modalities, ranging from psychotherapy to pharmacotherapy, have long served as the cornerstone of anxiety management, offering pathways to relief for those burdened by its relentless grip. Generalized Anxiety Disorder (GAD) is marked by excessive worry and anxiety about a wide range of everyday events or activities.
(Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, announces that the first patient has been dosed in a Phase 2 proof-of-concept clinical study investigating ANEB-001 as a potential treatment for acute cannabinoid intoxication.
People develop PTSD after experiencing a traumatic event or an event that is perceived as such. Does cannabis aid in forgetting traumatic events or just boosts dopamine, increasing the overall feelings of pleasure? Sufferers also avoid thinking or talking about the traumatic event.
OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.
16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. “It is our duty as physicians to understand the available treatment options for our patients, and medical cannabis treatments have emerged as an important clinical tool.
Medical marijuana is a potential treatment for insomnia, and it offers an alternative to traditional pharmaceuticals. It is often caused by life events such as stress, anxiety, or a significant change in routine. Chronic insomnia often requires a more comprehensive treatment approach.
OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug. ” About The Study.
Additionally, nausea is a common side effect of cancer treatments, migraines, pregnancy, and more. But what about CBD , which is usually considered the “more medical” cannabinoid? Chemovars are a classification of cannabis based on the dominant cannabinoid , which is the most direct indicator of experience. CBDA and nausea.
Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. While cannabidiol was associated with a reduction in reported seizure events (RR?=?0.59, 0.59, 95% CI [0.36–0.97]),
Cannabis has long been used as a treatment for all types of headaches and migraines, and was “highly esteemed as a headache remedy” by prominent physicians as far back as the 19th century. A series of studies carried out over the past decade have attested to the potential benefits of medical cannabis in chronic pain treatment.
Before getting to this news, let’s take a minute to review some of the prior research supporting marijuana for the treatment PTSD. To date, there is no pharmaceutical product targeted specifically for the treatment of PTSD. Medical Marijuana: More Effective Than Pharmaceuticals? How CBD Targets Fear-Related Memories. Get Started.
So, whether you’re a patient looking for alternatives, a caregiver seeking new treatment options, or a curious mind interested in the intersection of cannabis and mental health, this discussion is for you. Let’s journey together into the promising world of medical cannabis and its potential for mental health treatment.
The global chronic pain treatment market is predicted to progress at a CAGR of 6.5% It is an honour and privilege to be in the position to use novel psychedelic treatments to solve the complex puzzle that is chronic pain. These statements relate to future events or future performance. billion in 2030. 3 Psychol Res Behav Manag.
Progressive Treatments Solutions’ label Mozey is the latest brand to offer an entry in the shape of a 1g disposable Bomb Berry Pop vape. total cannabinoids. To learn more about cannabis-friendly events in Illinois, visit here. As the summer marches on, so does my search for great summer-themed products.
In recent years, research has revealed that two of marijuana’s two major cannabinoids — THC and CBD — can interact with the human endocannabinoid system to influence bone healing and regeneration. THC, CBD & THE ECS. Find Out if You Qualify. You may be eligible for medical marijuana! Get Started. Join 80K+ Subscribers!
Delta-8 THC is one of over 100 cannabinoids produced naturally by the cannabis plant but is not found in significant amounts in the cannabis plant. Some concerns include variability in product formulations and product labeling, other cannabinoid and terpene content, and variable delta-8 THC concentrations. brownies, gummies).
It’s been a while since we’ve reviewed a new strain from the team at Progressive Treatment Solutions , so when I spotted a new drop from the company’s Paul Bunyan label, I was instantly intrigued. This batch of flower tested at 1.38% CBGa, 0.48% Delta 9 THC, 23.13% THCa, and 24.99% total cannabinoids.
A certain “safe” feeling comes with knowing I have anxiety treatment at my fingertips, which is why I keep a vape on hand at all times. total cannabinoids. total cannabinoids. To learn more about cannabis-friendly events in Illinois, visit here. This batch of oil tested at 82.35% THC, 0.29% CBD, and 82.7%
One of the negative effects of the market focus on THC percentages is the lost effort and attention that could be dedicated to the long list of minor cannabinoids. Spectra’s V-RSO 1:1 + Sleep Vape is a disposable vape with a blended cannabinoid and terpene oil. To learn more about cannabis-friendly events in Illinois, visit here.
In Canada today, close to 70% of all those surveyed aged 19+ believe that cannabis is an alternate form of treatment to some medical conditions according to Vividata’s Vivintel , the nation’s largest syndicated cannabis consumer study. We are partnering with Canopy Growth to offer a unique event of fun and canna-learning.
–(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., It is our hope that this study may embolden clinicians and patients to effectively partner in considering these treatments.”. Under the Leadership of Nicolas Schlienz, Ph.D., About Realm of Caring.
Simon is not alone, one study reviewed online forum posts about cannabis and ADHD and found that 25% of posts indicated therapeutic benefits from this treatment – with statements like “While you are high … you will be able to focus much, much better than you normally would” and “(cannabis) helps me greatly with my ADHD.”
Progressive Treatment Solutions produces its own label of RSO called The Antidote, so I headed to Consume Marion and picked up a half-gram Chem 91 to review. This half-gram RSO extraction tested at 16.5mg of CBDa, 333.35mg of THC, and 375.15mg total cannabinoids. To learn more about cannabis-friendly events in Illinois, visit here.
Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). Health Europa reports. PROGRAMME.and.ABSTRACTS.
Over the past few decades, there has been an increased interest in leveraging cannabis and cannabinoids for medicinal purpose. 2 Types of THC Impact THC has broad pharmacological spread which means there are many opportunities for is to cause adverse Drug Events or unpredictable drug-drug interactions.
Progressive Treatment Solutions has joined the flood, bringing Mozey to Illinois, a label it has already built in Michigan and Arizona. This vape tested at 79.54% THC and 82.07% total cannabinoids. To learn more about cannabis-friendly events in Illinois, visit here. For more Illinois News Joint reviews, visit here.
I’ve been hunting for Rum Runner from Progressive Treatment Solutions since January when I watched it come and go from the menu. total cannabinoids. To learn more about cannabis-friendly events in Illinois, visit here. You don’t know what you’ve got til it’s gone, even at the dispensary.
Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. The market for medical cannabis in Germany.
The ECS is activated by cannabinoids that exist naturally in the body, called endocannabinoids, but also by cannabinoids found in cannabis — phytocannabinoids. . There is also the matter of how CBD and other cannabinoids interact with the liver, which is responsible for metabolizing drugs like birth control. Shutterstock).
Front Porch , a label from Progressive Treatment Solutions , offers an indica-leaning Moonlight version of its infused prerolls as a 2.5-gram This pack tested at 0.32% CBG, 2.47% CBGa, 0.13% CBDa, 2.51% Delta 9 THC, 46.54% THCa, and 51.97% total cannabinoids. To learn more about cannabis-friendly events in Illinois, visit here.
Recently, I came across the Progressive Treatment Solutions , version of this strain at Consume Marion and eagerly picked up a sample to see how it stacked up to my past experiences. This batch of flower tested at 0.45% CBGa, 0.77% Delta-9-THC, 19.86% THCa, and 21.08% total cannabinoids.
We aren’t shy about being fans of citrus-heavy energetic sativa here at Illinois News Joint , which is why I already had sampled one of Progressive Treatment Solutions’ flagship sativa, Orange Soda, as a crumble and preroll. This batch of flower tested at 0.55% CBGa, 0.44% Delta-9-THC, 22.38% THCa, and 23.37% total cannabinoids.
When I picked up a batch of new Progressive Treatment Solutions samples from Consume Marion , I was excited to see Panama MAC #5 on the list. total cannabinoids. To learn more about cannabis-friendly events in Illinois, visit here. Panama MAC #5 is a hybrid cross of Macnanna and Panama Red #5.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content